Does untreated hearing loss exacerbate cognitive decline?

Colleagues at Johns Hopkins University have been researching aspects of hearing loss and cognition with the ACHIEVE study, a randomised trial to determine the efficacy of hearing intervention on reducing cognitive decline in older adults.

The ACHIEVE study is a randomised trial of older adults aged 70-84 with untreated hearing loss who were free from substantial cognitive impairment, conducted at four U.S. sites. 977 total participants were recruited from two study populations, and 739 healthy community volunteers were newly recruited to the study.

According to the researchers, at the start of the trial, all study participants generally had mild to moderate hearing loss very typical of older adults, but no substantial cognitive impairment.

The three-year intervention included the use of hearing aids, a hearing “toolkit” to assist with self-management and ongoing instruction and counselling with an audiologist. The comparison health education control group had talk sessions with a health educator about chronic disease prevention. The total study population was analysed, hearing intervention versus health education control; the ARIC and community subgroups were also analysed in this manner. The primary endpoint was three-year change in a comprehensive neurocognitive testing battery, which included procedures to help ensure that hearing loss would not affect the results.

The findings show that in a subgroup of older adults with hearing loss who were at higher risk of cognitive decline, using hearing aids for three years cut cognitive decline in half.

According to the ACHIEVE researchers, the hearing intervention may slow down the decline in thinking and memory by making listening easier for the brain or helping people remain more socially and physically active.

Hearing loss and cognitive decline in social activity

Results from the study, the largest randomised, controlled clinical trial of hearing aids for reducing long-term cognitive decline in older adults, were reported for the first time at the Alzheimer’s Association International Conference 2023 in Amsterdam, Netherlands. The findings from the ACHIEVE study were simultaneously published in The Lancet.

https://aaic.alz.org/releases_2023/hearing-aids-slow-cognitive-decline.asp

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01406-X/fulltext

If you have any further questions or need additional information concerning hearing loss or hearing aids in Taunton and Somerset, please don't hesitate to contact us.

With thanks to HearingTracker.

About the Alzheimer’s Association International Conference® (AAIC®)

The Alzheimer’s Association International Conference (AAIC) is the world’s largest gathering of researchers from around the world focused on Alzheimer’s and other dementias. As a part of the Alzheimer’s Association’s research program, AAIC serves as a catalyst for generating new knowledge about dementia and fostering a vital, collegial research community.

About the Alzheimer’s Association®

The Alzheimer’s Association is a worldwide voluntary health organisation dedicated to Alzheimer’s care, support and research. Our mission is to lead the way to end Alzheimer’s and all other dementia by accelerating global research, driving risk reduction and early detection, and maximising quality care and support. Our vision is a world without Alzheimer’s and all other dementia®. Visit alz.org or call 800.272.3900.

Previous
Previous

Starkey Genesis AI hearing aids…

Next
Next

Association between hearing aid use and dementia: an analysis of the UK Biobank data.